Ropinirole prolonged release maintains a positive treatment response in patients with advanced Parkinson's disease (PD) not optimally controlled with L-Dopa

被引：0
|
作者：
Ruzicka, E. [1 ]
Hunter, B. [2 ]
Giorgi, L. [3 ]
Hersh, B. [4 ,5 ]
机构：
[1] Charles Univ Prague, Prague, Czech Republic
[2] GlaxoSmithKline Inc, Harlow, Essex, England
[3] GlaxoSmithKline Inc, Greenford, Middx, England
[4] Harvard Vanguard Med Associates, Boston, MA USA
[5] Harvard Univ, Sch Med, Boston, MA USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2009年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：522 / 522
页数：1
相关论文
共 50 条
  • [41] Lack of a pharmacokinetic interaction at steady state between ropinirole and L-dopa in patients with Parkinson's disease
    Taylor, AC
    Beerahee, A
    Citerone, DR
    Cyronak, MJ
    Leigh, TJ
    Fitzpatrick, KL
    Lopez-Gil, A
    Vakil, SD
    Burns, E
    Lennox, G
    PHARMACOTHERAPY, 1999, 19 (02): : 150 - 156
  • [42] A multicenter double blind study of ropinirole as an adjunct to L-dopa in Parkinson's disease
    Kreider, M
    Knox, S
    Gardiner, D
    Wheadon, D
    NEUROLOGY, 1996, 46 (02) : 67003 - 67003
  • [43] Peculiarities of L-DOPA treatment of Parkinson's disease
    Kostrzewa, RM
    Nowak, P
    Kostrzewa, JP
    Kostrzewa, RA
    Brus, R
    AMINO ACIDS, 2005, 28 (02) : 157 - 164
  • [44] The PREPARED Study: An Assessment of Symptom Control in Patients with Advanced Parkinson's Disease Receiving Treatment with Adjunctive Ropinirole Prolonged Release or Ropinirole Immediate Release
    Stocchi, Fabrizio
    Giorgi, Luigi
    Hunter, Brian
    Schapira, Anthony
    NEUROLOGY, 2009, 72 (11) : A413 - A413
  • [45] Ropinirole 24-hour prolonged release in advanced Parkinson's disease: Relationship between treatment response and disease severity
    Sethi, K. D.
    Stocchi, F.
    Giorgi, L.
    MOVEMENT DISORDERS, 2007, 22 : S92 - S93
  • [46] ROPINIROLE, A PLACEBO-CONTROLLED STUDY OF EFFICACY AS ADJUNCT THERAPY IN PARKINSONIAN-PATIENTS NOT OPTIMALLY CONTROLLED ON L-DOPA
    PEREZAHARON, J
    ABBOT, RJ
    PLAYFER, JR
    FOSTER, J
    WELLS, TJ
    BROOKS, D
    SPOKES, G
    SAGAR, H
    KORCZYN, AD
    NEUROLOGY, 1994, 44 (04) : A244 - A244
  • [47] PREPARED: Comparison of Prolonged and Immediate Release Ropinirole in Advanced Parkinson's Disease
    Stocchi, Fabrizio
    Giorgi, Luigi
    Hunter, Brian
    Schapira, Anthony H. V.
    MOVEMENT DISORDERS, 2011, 26 (07) : 1259 - 1265
  • [48] The evolution of the acute response to L-dopa in Parkinson's disease
    Hughes, AJ
    Lees, AJ
    MOVEMENT DISORDERS, 2002, 17 : S97 - S98
  • [49] Ropinirole is highly effective on motor function as adjunct therapy to L-DOPA in Japanese patients with Parkinson's disease
    Mizuno, Y
    Abe, T
    Hasegawa, K
    Kano, S
    Kondo, T
    Yamamoto, M
    MOVEMENT DISORDERS, 2004, 19 : S167 - S167
  • [50] THE L-DOPA RESPONSE IN PATHOLOGICALLY CONFIRMED PARKINSON'S DISEASE
    Pitz, Vanessa
    Malek, Naveed
    Grosset, Katherine A.
    Grosset, Donald G.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (10):
12345